SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
Clinical trial NCT00418938 · COMPLETED
Trial details
- NCT number
- NCT00418938
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2012-05-10
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.